The Nasdaq Biotechnology Index closed down nearly 2%, with a cumulative decline of over 8.4% this week
On Friday, constituent stock Iovance Biotherapeutics fell by 44.80%, Savara dropped by 11.49%, Esperion decreased by 10.60%, Lexeo Therapeutics fell by 10.33%, and Novavax dropped by 10.29%; Alector, on the other hand, rose by 13.46% to rank third, Corvus Pharmaceuticals increased by 32.24%, and Phathom Pharma rose by 37.12%
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments